http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014172448-A3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dcb3d9cd08b663d4530071e75777211f |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-2863 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-00 |
| filingDate | 2014-04-16-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_794b76942b5a45739aef0299e72b9e1d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5f8d57fe0431f5fad44a9905de6bdeab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6d731fc3c742466b213362aac0f6da1 |
| publicationDate | 2015-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | WO-2014172448-A3 |
| titleOfInvention | Antibodies directed against activin receptor type ii (actrii) |
| abstract | The invention relates to an isolated immunoglobulin heavy chain polypeptide and an isolated immunoglobulin light chain polypeptide that bind to an activin receptor type II (ActRII) protein (e.g., either or both of ActRIIA and/or ActRIIB). The invention provides an ActRII-binding agent that comprises the aforementioned immunoglobulin heavy chain polypeptide and immunoglobulin light chain polypeptide. The invention also provides related vectors, compositions, and methods of using the ActRII-binding agent to treat an ActRII-mediated disease. |
| priorityDate | 2013-04-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.